Rechercher dans ce blog

Friday, January 26, 2024

Measles is “growing global threat,” CDC tells doctors in alert message - Ars Technica

A baby with measles.
Enlarge / A baby with measles.

The Centers for Disease Control and Prevention is putting clinicians on alert about the growing risk of measles cases and outbreaks amid a global surge in transmission.

In an outreach message sent Thursday, the CDC told clinicians to look out for patients who have a rash accompanied by a fever and other symptoms of measles, as well as patients who have recently traveled to countries with ongoing measles outbreaks.

Between December 1, 2023, and January 23, 2024, there have been 23 confirmed measles cases in the US, including seven direct importations by international travelers and two outbreaks with more than five cases each, the CDC noted. Most of the cases were in unvaccinated children and teens.

Measles outbreaks in the US are typically sparked by unvaccinated or undervaccinated US residents who pick up the infection abroad and then, when they return, transmit the disease to pockets of their communities that are also unvaccinated or undervaccinated.

Globally and in the US, vaccination rates against measles—via the measles, mumps, and rubella vaccine (MMR)—have fallen in recent years due to pandemic-related health care disruption and vaccine hesitancy fueled by misinformation.

"The increased number of measles importations seen in recent weeks is reflective of a rise in global measles cases and a growing global threat from the disease," the CDC's outreach message, titled "Stay Alert for Measles Cases," read.

According to data from the World Health Organization, the European region saw an over 40-fold rise in measles cases in 2023 as compared with 2022. The region tallied over 42,200 measles cases last year, compared with just 941 in 2022.

This week, the WHO reported a rapid escalation of measles cases in Kazakhstan (which the WHO considers part of the European region). Kazakhstan has recorded the highest incidence of measles cases in the region, with 13,677 cases in 2023. That corresponds to over 639 cases per million in the population. In the news release Tuesday, Kazakhstan's health minister reported that there are "currently 2,167 children in hospital with measles, 27 of them in a serious condition."

The outbreak is largely spurred by unvaccinated children who missed their routine immunizations during the pandemic. Sixty-five percent of the reported measles cases are in children under age 5, the WHO noted. The country is now trying to catch children up on their vaccines to curb the outbreak.

"Measles is highly infectious, but fortunately, can be effectively prevented through vaccination," WHO's Regional Director for Europe, Hans Henri P. Kluge, said in the news release. "I commend Kazakhstan for the urgent measures being taken to stop the spread of this dangerous disease."

Meanwhile, measles is flaring up in many other places. Last week, the UK Health Security Agency warned of the potential for an ongoing measles outbreak to spread. As of January 18, there were 216 confirmed cases and 103 probable cases in the West Midlands region since October 2023. Authorities warned that any areas with low MMR vaccination rates are at risk of an outbreak.

The vast majority of Americans have received their MMR vaccines on schedule. In this case, the two standard, recommended doses are considered 97 percent effective against measles, and the protection is considered for life. But anyone who is unvaccinated or undervaccinated is at high risk of infection in the event of an exposure. The virus can linger in air space for up to two hours after an infected person leaves the area, the CDC notes, and is highly infectious—up to 90 percent of unvaccinated people exposed will fall ill. Once infected, people are infectious from four days before the telltale measles rash develops to four days afterward.

Adblock test (Why?)



Health - Latest - Google News
January 27, 2024 at 05:02AM
https://ift.tt/2M4Styv

Measles is “growing global threat,” CDC tells doctors in alert message - Ars Technica
Health - Latest - Google News
https://ift.tt/fX3c2Dq

Cameroon's babies get world-first RTS,S malaria vaccine - BBC.com

[unable to retrieve full-text content]

  1. Cameroon's babies get world-first RTS,S malaria vaccine  BBC.com
  2. Malaria vaccine brings surprise benefit to children : Goats and Soda  NPR
  3. News at a glance: Long-awaited malaria shots, risks of face recognition technology, and Japan's first moon landing  Science
  4. New GSK malaria vaccine, Mosquirix, is rolled out in Africa  STAT
  5. First malaria vaccine program benefits children  Deseret News


Health - Latest - Google News
January 26, 2024 at 09:50PM
https://ift.tt/V4svK2h

Cameroon's babies get world-first RTS,S malaria vaccine - BBC.com
Health - Latest - Google News
https://ift.tt/fX3c2Dq

Thursday, January 25, 2024

Measles in the U.K.: Health authorities warn outbreak could grow - NBC News

LONDON — A serious outbreak of measles in England could grow to tens of thousands of cases, health experts there have warned, as Europe grapples with a spike in the highly contagious disease.

The U.K. Health Security Agency said Friday that since October, there have been 216 confirmed cases and 103 probable cases in the West Midlands region, an urban part of England centered on the city of Birmingham, where around 80% of the cases were recorded. That’s higher than last year’s total of 209 measles cases and the 2022 tally of 53.

Last year, the government warned that a measles outbreak in London could lead to between 40,000 and 160,000 cases there if the vaccination rate did not improve. The rate in England has been falling for years due to misinformation and declining community health budgets. 

Around 89% of children in England have received their first measles, mumps and rubella (MMR) vaccine dose by age 2, according to the state-run National Health Service — down from 93% a decade ago. The World Health Organization considers 95% the necessary threshold to maintain herd immunity. 

A British information campaign is now urging people to ensure their children get the vaccination.

British lawmaker Maria Caulfield, who was previously the minister of state for health, laid bare the scale of the challenge when she told the House of Commons on Monday that more than 3.4 million children under 16 are not vaccinated against measles. 

In Europe overall, Hans Kluge, the World Health Organization’s director for the region, warned Wednesday that there had been 42,200 measles cases across 41 countries in 2023 — a nearly 45-fold increase from the 941 recorded the previous year. He said last month that nearly 21,000 people had been hospitalized.

A crisis is also building in central Asia, where more than 13,600 cases were recorded in 2023, the majority among unvaccinated children under 14, the WHO said.

Three U.S. states have also recorded measles cases in the last month. Philadelphia has confirmed at least eight locally acquired cases, in addition to one “imported” case that prompted a health alert in December. Camden County, New Jersey, confirmed a case on Jan. 13, then Georgia health officials confirmed the state’s first case in four years soon after: an unvaccinated resident in Atlanta. 

Measles is most common in children. The disease is characterized by a red, blotchy rash that usually follows a high fever, cough, runny nose and red, watery eyes. Around 1 in 5 unvaccinated people with measles are hospitalized, and up to 3 out of 1,000 children with measles die from complications such as pneumonia or swelling of the brain, according to the U.S. Centers for Disease Control and Prevention

The MMR vaccine is offered to children in Britain starting at 12 months, with a second dose shortly after they turn 3. Children in the U.S. get their second dose between 4 and 6 years old. Two shots are 97% effective, according to the CDC. 

“Even if you reach them, it’s really difficult to keep such high levels of vaccination sustained over a long period,” said Helen Bedford, a professor at University College London’s Great Ormond Street Institute of Child Health. “You get there, the disease goes away, people think, ‘Oh, well, the disease has gone away; I don’t need to vaccinate.’” 

Several other factors have fueled England’s vaccination challenges, experts said. One is that uptake remains especially low among low-income and more ethnically diverse groups, according to a 2021 NHS study in southeast England.

“It’s poor people, people who are highly mobile and don’t stay in one place,” said Azeem Majeed, professor of primary care and public health at Imperial College London. “In regards to messaging, the NHS needs to be more proactive on this.”

On Thursday, in an effort to reach non-English speakers, the local council in the borough of Brent released a video about measles in Romanian.

A second factor is a now-discredited study published in 1998 that falsely claimed the MMR vaccine was linked to autism. The paper was partially retracted in 2004, but by then vaccine uptake had dipped to 81%. The study was fully retracted in 2010 and its author, Andrew Wakefield, was removed from the U.K. medical register. 

Thousands of children born in the late ’90s and the early 2000s are now unvaccinated adults.

“It’s this combination of low uptake about 20 years ago, so you’ve got lots of young adults that are susceptible, and then over the years an accumulation of susceptible people, particularly in some parts of London,” Bedford said.

However, Bedford doesn’t consider vaccine hesitancy and the spread of conspiracy theories to be the main problem. British parents’ confidence in vaccines is as high as 90%, according to a 2022 study.

“The anti-vaccine movement is very, very small, but it has a very loud voice,” she said. “So I think it’s important not to get too hooked on that because there are lots of things we can do. And if we just focus on anti-vaccine, it’s much more difficult to know what to do.”

Instead, Bedford pointed a finger at two other factors: a reduction in community nurses and reforms made to the NHS — namely the 2013 decision to spread the responsibility for vaccines across several agencies rather than one.

What’s more, she said, there is a lingering opinion among some Britons that measles is a trivial childhood illness, which is a dangerous view.

“In a best-case scenario, measles is a nasty disease that makes children feel very ill. But of course there is a recognized significant complication rate, with ear infections, pneumonia, inflammation of the brain and, yes, it can kill you,” Bedford said. 

This week, doctors’ clinics in the West Midlands area urged patients not to turn up unannounced if they suspect they have measles: “Call ahead, that way if you do have measles — you won’t pass it on to others — it can be a fatal disease if someone has a weak immune system,” a public information flyer said.

Patrick Smith reported from London and Aria Bendix from New York.

Adblock test (Why?)



Health - Latest - Google News
January 26, 2024 at 05:45AM
https://ift.tt/tYmhQ74

Measles in the U.K.: Health authorities warn outbreak could grow - NBC News
Health - Latest - Google News
https://ift.tt/1MKzdrX

Wednesday, January 24, 2024

COVID variant JN.1 no more severe than previous strains, CDC data shows - Fox News

Join Fox News for access to this content

Plus get unlimited access to thousands of articles, videos and more with your free account!

Please enter a valid email address.

The Centers for Disease Control and Prevention (CDC) announced this week that data indicates the current dominant strain of COVID-19 is no more severe than previous forms.

The JN.1 variant, currently the most common strain in the country, has no more severity than others, according to a report published Monday by the CDC.

"CDC continues to learn more about JN.1, but currently there is no evidence that it causes more severe disease," the report stated.

WHO PANDEMIC TREATY 'EQUITY THEATER,' PENCE ADVOCACY GROUP SAYS, URGES US WITHDRAW FROM 'UNSALVAGEABLE BODY'

JN.1 variant

JN.1 is currently the most dominant strain of SARS-CoV-2 after yet another mutation. (iStock)

It continued, "Current COVID-19 vaccines are expected to increase protection against JN.1, as they do against other variants, by helping prevent severe illness."

JN.1, which is currently the country’s fastest growing variant, is expected to continue to increase in prevalence among COVID cases, the CDC stated. It is very similar to the BA.2.86 variant, which is an omicron subvariant that emerged in August.

It is now responsible for an estimated 85.7% of cases in the U.S. as of Jan. 22.

WASHINGTON POST URGES GOVERNMENT TO UNDERSTAND 'WHAT SOCIETY STANDS TO LOSE FROM LOCKDOWNS'

CDC logo

A general view of the Centers for Disease Control and Prevention headquarters in Atlanta. (REUTERS/Tami Chappell/File Photo)

Despite its quick growth, the agency has said "there is no evidence that JN.1 presents an increased risk to public health relative to other currently circulating variants," as it does not appear to cause increased severity of illness.

The report was affirmed by CDC official Dr. Eduardo Azziz-Baumgartner during a webinar.

"There are early signals that that may not be the case," Azziz-Baumgartner said when asked if the variant was more severe than past strains, though emphasizing that individuals could experience the virus differently.

CLICK HERE TO GET THE FOX NEWS APP

COVID vaccine

A doctor loads a dose of Pfizer COVID-19 vaccine into a syringe at a clinic in Worcester, Massachuetts. (AP Photo/Steven Senne)

"Now, it's important to remember that how a virus affects an individual is a unique 'n' of one," Azziz-Baumgartner said. "It could be very severe. People could die from a virus that, to the general population, may be milder."

The vaccines, tests and treatments that are currently available are expected to be effective against JN.1.

Fox News Digital's Melissa Rudy contributed to this report.

Adblock test (Why?)



Health - Latest - Google News
January 24, 2024 at 10:57PM
https://ift.tt/YmbWGMU

COVID variant JN.1 no more severe than previous strains, CDC data shows - Fox News
Health - Latest - Google News
https://ift.tt/K4f71zQ

COVID variant JN.1 is not more severe, early CDC data suggests - CBS News

Early data from hospitals suggests the latest COVID variant, known as JN.1, is not leading to more severe disease, a Centers for Disease Control and Prevention official said Monday, as the agency has tracked the strain's steep rise to an estimated 85.7% of COVID-19 cases nationwide.

The agency is still waiting for more weeks of data to lay out its more detailed assessment of JN.1's impact this season, the CDC official, Dr. Eduardo Azziz-Baumgartner, said at a webinar with testing laboratories hosted by the agency this week. 

Asked if JN.1's symptoms seemed to be more severe compared to previous waves, he said "there are early signals that that may not be the case," based on electronic medical record cohorts and other data.

"Now, it's important to remember that how a virus affects an individual is a unique 'n' of one," he added. "It could be very severe. People could die from a virus that, to the general population, may be milder." 

Azziz-Baumgartner told the webinar the CDC hopes to release more details about JN.1's severity "during the next couple weeks" as more data on the virus accumulates. 

So far, the CDC has been careful to say that there was "no evidence" JN.1 was causing more severe disease, even as it contributed to the spread of the virus this winter.

It is not clear when the CDC's new assessment of JN.1 is scheduled to be published. A CDC spokesperson was not able to immediately respond to a request for comment.

Scientists at the CDC and other federal health agencies have also so far not moved to deem JN.1 a standalone "variant of interest," in a break from the WHO's decision to step up its classification of the lineage last month. 

The WHO said Friday that there were "currently no reported laboratory or epidemiological reports" linking JN.1 or its other variants of interest to increased disease severity.

CDC's early findings about JN.1 come as the agency has begun to see a slowing of respiratory virus trends after a peak over the winter holidays. 

The agency's disease forecasters also concluded earlier this month that JN.1's spread did not warrant them stepping up their assessment of COVID-19's threat this winter, noting hospitalization rates appeared to be lower than they were last season.

COVID-19 hospitalizations this season continued to outpace influenza nationwide, the agency's data suggests, and weekly rates of both stopped short of topping previous record highs. 

Azziz-Baumgartner cautioned data lags could be muddying the picture, as hospitals catch up on delayed reporting of their weekly admissions. Officials have also been closely watching for possible signs of a renewed increase in the spread of influenza, as has been seen in some previous seasons before the COVID-19 pandemic.

Some jurisdictions have also been reporting a strain on hospitals, especially in New England, he said. CDC figures tally the region's hospital capacity rate as the worst in the country. 

Massachusetts General Hospital warned last week it was taking steps to address an "unprecedented overcrowding" crisis, along with other hospitals in the state.

Adblock test (Why?)



Health - Latest - Google News
January 24, 2024 at 04:31AM
https://ift.tt/fCrOwQI

COVID variant JN.1 is not more severe, early CDC data suggests - CBS News
Health - Latest - Google News
https://ift.tt/K4f71zQ

'Alarming rise' in measles cases in Europe as 'national incident' declared in UK - Euronews

With a "national incident" over measles in the UK, what’s the situation in Europe?

Europe is experiencing an "alarming rise" in measles cases, the World Health Organization (WHO) warned on Tuesday, with a more than 30-fold rise across the region in 2023.

More than 30,000 measles cases were reported by 40 of the WHO European region’s 53 member states between January and October last year, compared to 941 cases in 2022.

The increase in the number of cases is compounded by the hospitalisation of 21,000 people and five measles-related deaths.

The WHO says this upward trend is expected to continue if urgent measures are not taken to prevent further spread.

The UK's health agency has already declared a “national incident” over an outbreak in central England.

The virus practically disappeared in Europe during the COVID-19 lockdowns, but "the overall number of measles cases in the EU/EEA has been steadily increasing since June 2023," the European Centre for Disease Prevention and Control (ECDC) said in its latest weekly threats report.

Alongside the UK, Romania is on red alert. Last December, the country’s health ministry declared a national measles epidemic following a worrying rise in cases and a high number of hospitalisations among infected children.

Since the announcement, four unvaccinated people - three babies and one adult - died due to measles, according to local media and the National Institute of Public Health. The latter confirmed 2,805 cases of the virus in Romania last year.

Austria has been fighting measles since the beginning of 2023, with almost 200 cases recorded through the epidemiological reporting system.

In France, a measles outbreak started in a school in the southeastern commune of Guilherand-Granges in September. By mid-November, 64 cases were confirmed, two of which had to be hospitalised, the regional health agency reported.

Germany recorded 57 cases last year, which was higher than in 2022 but lower than pre-pandemic levels.

Measles vaccination coverage in Europe

The ECDC says that more measles cases are expected in the majority of EU/EEA countries since vaccination coverage is "suboptimal". WHO Europe, meanwhile, warned that the virus resurgence was largely attributed to backsliding in vaccination coverage.

The average vaccination coverage in the EU/EEA has been falling since 2020. The latest data from the ECDC show that coverage for the second dose in 2022 was around 89.7 per cent.

Hungary (99 per cent), Slovakia and Portugal (96 per cent) are the EU countries with the highest levels of measles vaccination, while Estonia (68 per cent) and Romania (71 per cent) have the lowest levels.

The UK's health authorities warned last Friday that the surge in the West Midlands could spread to other towns and cities unless urgent action is taken to boost vaccination uptake.

According to the UK Health Security Agency (UKHSA), as of last Thursday, there had been 216 confirmed measles cases and 103 probable cases in the West Midlands since October 2023, the majority being in children aged under 10.

"With vaccine uptake in some communities so low, there is now a very real risk of seeing the virus spread in other towns and cities," said Jenny Harries, chief executive of the UKHSA.

She stressed the importance of getting two doses of the measles, mumps and rubella (MMR) vaccine for lifelong protection, adding that "it’s never too late to catch up".

"Children who get measles can be very poorly and some will suffer life-changing complications. The best way for parents to protect their children from measles is the MMR vaccine," Harries said.

Siddhartha Datta, WHO Europe's regional adviser on immunisation, agrees. 

"The measles vaccines we have are safe and effective. They have been used for years now, and have been able to prevent so many deaths and diseases in the European region," he explained at a press conference last week.

Measles is a highly contagious viral illness that spreads easily when an infected person breathes, coughs or sneezes, according to the WHO, and "can cause severe disease, complications, and even death".

The virus is most common in children. Symptoms may include high fever, cough, runny nose and rash.

The two doses of the MMR vaccine are 96 per cent effective against measles, according to the Vaccine Knowledge Project, managed by the Oxford Vaccine Group.

Adblock test (Why?)



Health - Latest - Google News
January 23, 2024 at 11:07PM
https://ift.tt/zGW0ev2

'Alarming rise' in measles cases in Europe as 'national incident' declared in UK - Euronews
Health - Latest - Google News
https://ift.tt/K4f71zQ

Tuesday, January 23, 2024

Cameroon Launches First Malaria Vaccine Program for Children - VOA Learning English

Cameroon has begun the world’s first major malaria vaccine program for children.

The campaign launched Monday in the Central African nation. Health officials called the effort a major step in the fight against the disease across Africa. The continent accounts for about 95 percent of the world’s malaria deaths.

The World Health Organization (WHO) estimates the disease, which is spread through mosquitos, kills more than 600,000 people a year. Most of the deaths involve young children.

The vaccine, called RTS.S, was developed by British drug company GlaxoSmithKline (GSK). It is meant to work with other preventive measures, such as the use of bed nets, to fight the disease.

Cameroon is the first country to offer vaccine injections through a routine program after successful tests, or trials, were carried out in Ghana and Kenya. Cameroon hopes to vaccinate about 250,000 children this year and next.

FILE - Health officials prepare to administer a vaccine in the Malawi village of Tomali with the world's first vaccine against malaria in a pilot program in Tomali, Dec. 11, 2019. (AP Photo/Jerome Delay, File)
FILE - Health officials prepare to administer a vaccine in the Malawi village of Tomali with the world's first vaccine against malaria in a pilot program in Tomali, Dec. 11, 2019. (AP Photo/Jerome Delay, File)

The international vaccine alliance called Gavi has said 19 other countries aim to launch their own campaigns this year. About 6.6 million children in those countries are to receive malaria vaccinations in 2024 and 2025.

"For a long time, we have been waiting for a day like this," said Mohammed Abdulaziz. He is with the African Centers for Disease Control and Prevention. Abdulaziz spoke during a joint news briefing with the WHO, Gavi and other organizations.

Cameroon is using one of two recently approved malaria vaccines, called Mosquirix. When the WHO approved the vaccine two years ago, officials admitted it was not perfect. But they noted its use could sharply reduce severe infections and hospitalizations.

The GSK-produced shot is only about 30 percent effective. It requires four shots, or doses. Tests have shown the vaccine’s protection begins to weaken after several months. GSK has said it can only produce about 15 million doses of Mosquirix a year.

Some experts believe a second malaria vaccine developed by Oxford University and approved by the WHO in October may be a better solution. That vaccine, called R21, is less costly and only requires three doses.

FILE - A mother holds her baby receiving a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya on Oct. 30, 2009. (AP Photo/Karel Prinsloo, File)
FILE - A mother holds her baby receiving a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya on Oct. 30, 2009. (AP Photo/Karel Prinsloo, File)

Launching the second vaccine is expected to result in enough vaccine supply “to meet the high demand and reach millions more children," said Kate O'Brien. She is the WHO's director of vaccinations.

"Having two vaccines for malaria will help to close the huge gap between demand and supply and could save tens of thousands of young lives, especially in Africa," said WHO Director-General Tedros Adhanom Ghebreyesus.

India’s Serum Institute – which helped develop the R21 vaccine –has said it could produce up to 200 million doses of it a year. Gavi has said that vaccine could be launched in May or June.

Some experts have raised questions about the long-term effectiveness of the vaccines. They have questioned whether attention and financing should be drawn away from the wider fight against the disease using established prevention methods.

But health experts at the news conference said the new vaccine launch included community efforts aimed at supporting the campaign. Officials advised individuals on vaccine safety and have urged them to continue to use existing protective methods alongside the vaccines.

I’m Bryan Lynn.

The Associated Press, Reuters and Agence France-Presse reported on this story. Bryan Lynn adapted the reports for VOA Learning English.

______________________________________________

Words in This Story

bed net – n. a large piece of material made with crossed threads and holes that is placed over a bed and is designed to keep out insects

routine – adj. done regularly

gap – n. an empty space or hole in the middle of or between two things

Adblock test (Why?)



Health - Latest - Google News
January 23, 2024 at 04:58AM
https://ift.tt/sxvWZIX

Cameroon Launches First Malaria Vaccine Program for Children - VOA Learning English
Health - Latest - Google News
https://ift.tt/G6xoAcf

Monday, January 22, 2024

Cameroon begins routine malaria shots in global milestone - Reuters

[unable to retrieve full-text content]

  1. Cameroon begins routine malaria shots in global milestone  Reuters
  2. Cameroon starts world-first malaria mass vaccine rollout | BBC News  BBC News
  3. World first: malaria vaccine rollout begins in Cameroon  The Guardian
  4. Cameroon is starting the world's first malaria vaccine program for children | DW News  DW News
  5. Cameroon starts world-first malaria mass vaccine rollout  BBC.com


Health - Latest - Google News
January 23, 2024 at 05:59AM
https://ift.tt/0bupL4E

Cameroon begins routine malaria shots in global milestone - Reuters
Health - Latest - Google News
https://ift.tt/G6xoAcf

Cameroon starts world-first malaria mass vaccine rollout - BBC.com

By Paul Njie & Natasha BootyBBC News, Yaoundé & London

AFP Daniella with her mother and twin brother.AFP
Eight-month-old Daniella, right, is the first Cameroonian child to get the jab

The world's first routine vaccine programme against malaria has started in Cameroon, in a move projected to save thousands of children's lives across Africa.

The symbolic first jab was given to a baby girl named Daniella at a health facility near Yaoundé on Monday.

Every year 600,000 people die of malaria in Africa, according to the World Health Organization (WHO).

Children under five make up at least 80% of those deaths.

Cameroon is offering the RTS,S vaccine free of charge to all infants up to the age of six months old.

Patients require a total of four doses. Health officials say these will be given at the same time as other routine childhood vaccines to make it easier for parents.

It comes after successful pilot campaigns in Kenya, Ghana and Malawi - where the vaccine caused a 13% drop in malaria deaths in children of eligible age, says Unicef.

The jab is known to be effective in at least 36% of cases, according to US researchers, meaning it could save over one in three lives.

While the rollout is undoubtedly a relief and a life-saver, its relatively low efficacy rate means that it is not a "silver bullet", argues Willis Akhwale at End Malaria Council Kenya.

But for medics it is an important additional tool in the fight against malaria alongside mosquito nets and malaria tablets.

"We have a capacity to considerably reduce the number of cases and deaths from malaria and accelerate the elimination of the disease," Cameroonian doctor Shalom Ndoula, who helped to lead the rollout in his country, told BBC Newsday.

Development of the RTS,S vaccine has taken 30 years of research by the British drug-maker GSK.

The World Health Organization, which approved the vaccine, hailed the launch in Cameroon as a historic moment in the global fight against the mosquito-borne disease.

'Safe, effective and free'

Fears and doubts among some Cameroonians about the safety and efficacy of the doses have raised concerns about vaccine hesitancy.

"When people say we are being used as guinea pigs, that's not particularly true," Wilfred Fon Mbacham, who is a Cameroonian king and also a professor of public health biotechnology specialising in malaria, told BBC Newsday.

"We as scientists have to do much more on what it is, and the benefits it has, so that we can calm their fears."

Vaccination official Daniele Ekoto at Monday's launch told the BBC she was reassuring mothers after administering doses to their children, insisting that "it's a vaccine that's safe, effective and free".

But for others the benefits are obvious.

"I decided to vaccinate my child to avoid malaria. It's a bad thing and when it affects a child, they can easily die," one mother told the BBC at the same vaccination centre in Soa, near Yaoundé, where Monday's launch happened.

In 2021, Africa accounted for 95% of malaria cases globally and about 96% of related deaths.

"I have prayed and waited all my life for this vaccine", Mr Mbacham told the BBC.

The WHO says Cameroon records about six million malaria cases every year, with 4,000 deaths in health facilities - most of them children below five.

Six-month-old children in 42 districts with the greatest rates of morbidity and mortality will receive four doses until the age of two.

Twenty other countries aim to roll out the programme this year, according to the global vaccine alliance, Gavi. Among them are Burkina Faso, Liberia, Niger and Sierra Leone.

There is already a big demand for doses, but only about 18 million are available for allocation before 2025, according to Gavi, the vaccine alliance.

It falls short of what is needed by the countries the alliance has recommended for approval.

The anticipated rollout of a second vaccine - R21 - developed by Oxford University, is expected to significantly increase the number of doses available for use.

This is to be manufactured by the Serum Institute of India, which aims to make 100 million doses per year, so long as it successfully passes the regulatory approvals following its recommendation for use by the WHO last year.

Additional reporting by Anne Soy



Copyright 2024 BBC. All rights reserved.  The BBC is not responsible for the content of external sites. Read about our approach to external linking.

Beta Terms By using the Beta Site, you agree that such use is at your own risk and you know that the Beta Site may include known or unknown bugs or errors, that we have no obligation to make this Beta Site available with or without charge for any period of time, nor to make it available at all, and that nothing in these Beta Terms or your use of the Beta Site creates any employment relationship between you and us. The Beta Site is provided on an “as is” and “as available” basis and we make no warranty to you of any kind, express or implied.

In case of conflict between these Beta Terms and the BBC Terms of Use these Beta Terms shall prevail.

Adblock test (Why?)



Health - Latest - Google News
January 22, 2024 at 07:48PM
https://ift.tt/r91zeNa

Cameroon starts world-first malaria mass vaccine rollout - BBC.com
Health - Latest - Google News
https://ift.tt/RT5ZX2j

First mass malaria vaccination campaign begins in Africa - Financial Times

[unable to retrieve full-text content]

First mass malaria vaccination campaign begins in Africa  Financial TimesView Full Coverage on Google News

Health - Latest - Google News
January 22, 2024 at 12:02PM
https://ift.tt/PF4CDkH

First mass malaria vaccination campaign begins in Africa - Financial Times
Health - Latest - Google News
https://ift.tt/RT5ZX2j

Sunday, January 21, 2024

N.Y. midwife administered 12.5K fake vaccines to children, including Staten Islanders - SILive.com

STATEN ISLAND, N.Y. -- The New York state Department of Health announced that it issued a $300,000 penalty as part of a Stipulation and Order signed by a Long Island midwife who falsified immunization records for roughly 1,500 school-aged children.

Jeanette Breen, a licensed midwife who operated Baldwin Midwifery in Nassau County, violated the Immunization Registry Law. Breen reportedly administered 12,449 fake immunizations as pretext for submitting falsified information into the New York State Immunization Information System (NYSIIS).

“Misrepresenting or falsifying vaccine records puts lives in jeopardy and undermines the system that exists to protect public health,” state Health Commissioner Dr. James McDonald said. “Let it be clear, the New York state Department of Health takes this issue seriously and will investigate and use all enforcement tools at its disposal against those who have been found to have committed such violations.”

Breen began this course of falsifying vaccinations at the beginning of the 2019-2020 school year, three months after non-medical exemptions were no longer considered for required school immunizations. In doing so, Breen supplied patients with the “Real Immunity Homeoprophylaxis Program,” which the state Health Department described as “a series of oral pellets marketed by an out-of-state homeopath as an alternative to vaccination.” These pellets are not authorized by the U.S. Food and Drug Administration (FDA) nor are they recognized and approved by the Centers for Disease Control and Prevention (CDC) or the state Health Department.

These fraudulent vaccinations did not include COVID vaccinations, but did include falsified immunizations for the following:

  • diphtheria
  • tetanus toxoid-containing and pertussis vaccine (DTaP or Tdap)
  • hepatitis B vaccine
  • measles, mumps and rubella vaccine (MMR)
  • polio vaccine
  • varicella (Chickenpox) vaccine
  • meningococcal conjugate vaccine (MenACWY)
  • booster doses of MenACWY
  • the Haemophilus influenzae type b conjugate vaccine (HiB) and pneumococcal conjugate vaccine (PCV)
  • flu vaccine
  • hepatitis A vaccine

Breen administered to children statewide, ranging as far as Erie county. According to a report by NBC, 28 false vaccinations were given to children on Staten Island, 113 in Brooklyn and 488 in Nassau.

Should the children affected by this incident wish to return to school, the Health Department said they must be fully up to date with all required immunizations, or at least be in the process of receiving any missing vaccinations.

“By intentionally falsifying immunization records for students, this licensed health care professional not only endangered the health and safety of our school communities but also undermined public trust,” state Education Commissioner Betty A. Rosa said. “We are pleased to have worked with our partners in government to bring this wrongdoer to justice. We remain committed to upholding the highest standards of health and well-being within our educational institutions.”

The settlement agreed upon by the Health Department and Breen includes the $300,000 penalty, permanent exclusion from NYSIIS, and the requirement that Breen refrain from ever administering a vaccination that must be reported to NYSIIS again.

“This enforcement action is the culmination of a first-of-its-kind investigation in which the Department’s Bureau of Investigations, Division of Legal Affairs, worked with the Department’s subject-matter experts to uncover a widespread scheme to falsify required school vaccinations,” Director of Investigations Joseph Giovannetti said. “Our thanks to the New York State Education Department for its assistance. Anyone involved in immunization fraud is on notice: Rooting out, combating, and preventing all forms of vaccination fraud is a top priority for the Bureau of Investigations, and we will continue to bring enforcement action against any offender who endangers the health of our communities and abuses our public health systems with this type of illegal activity.”

Adblock test (Why?)



Health - Latest - Google News
January 21, 2024 at 02:22AM
https://ift.tt/qpPRuzo

N.Y. midwife administered 12.5K fake vaccines to children, including Staten Islanders - SILive.com
Health - Latest - Google News
https://ift.tt/RT5ZX2j

Colon cancer killing young men, women at troubling rate: Study - NewsNation Now

(NewsNation) — Younger men and women are being diagnosed with colon cancer than ever before, according to a report from the American Cancer Society.

Colon cancer has become the leading cause of death among men younger than 50, and the number two cause of death in women of the same age group, according to the report,

Researchers pointed to the possibility that the COVID-19 pandemic caused delays in the diagnosis and treatment of cancer in 2020 because of health care setting closures and fear of virus exposure.

“We know that obesity plays a role and we’ve got rising obesity levels in this nation. We live sedentary lifestyles, we eat more processed foods, perhaps there are issues related to the gut microbiome, which are the bacteria that naturally live in the colon. And there are many different hypotheses that are out there, and it’s likely a multifactorial process,” said Dr. Ross Buerlein.

Buerlein, assistant professor of medicine at the University of Virginia, joined “NewsNation Prime” to discuss the troubling rates of colon cancer, saying regular screenings are the best form of prevention.

“You need to look out for signs and symptoms of colorectal cancer. Those are going to be things like blood in the stool or anemia that’s otherwise unexplained, particularly iron deficiency anemia, which can show itself as fatigue, weakness, shortness of breath. You can have new changes in bowel habits, abdominal pain, unexplained weight loss. And you’ve really got to advocate for yourself,” Buerlein said.

The report reveals increased rates of diagnosis in breast, prostate, uterine, pancreas, oral, liver, kidney and melanoma, as well as colorectal and cervical cancer in young adults.

Doctors advise colonoscopy screenings starting at age 45 but those with a family history of the illness may need to begin screening earlier.

Maintaining a healthy weight and limiting red meat are usually advised for those with a family history.

Adblock test (Why?)



Health - Latest - Google News
January 21, 2024 at 12:24PM
https://ift.tt/WN7onFu

Colon cancer killing young men, women at troubling rate: Study - NewsNation Now
Health - Latest - Google News
https://ift.tt/RT5ZX2j

Saturday, January 20, 2024

The Heart Surgery That Isn't as Safe for Older Women - The New York Times

Last Thanksgiving, Cynthia Mosson had been on her feet all day in her kitchen in Frankfort, Ind., preparing dinner for nine. She was nearly finished — the ham in the oven, the dressing made — when she suddenly felt the need to sit down.

“I started hurting in my left shoulder,” said Ms. Mosson, 61. “It got really intense, and it started to go down my left arm.” She grew sweaty and pale and told her family, “I think I’m having a heart attack.”

An ambulance sped her to a hospital where doctors confirmed that she had suffered a mild heart attack. They said testing revealed serious blockages in all her coronary arteries and told her, “You’re going to need open-heart surgery,” Ms. Mosson recalled.

When such patients head into an operating room, what happens next has a lot to do with their sex, a recent study in JAMA Surgery reported. The study reinforced years of research showing that male and female patients can have very different outcomes following an operation called coronary artery bypass grafting.

C.A.B.G. (pronounced like the vegetable) restores blood flow by taking arteries from patients’ arms or chests, and veins from their legs, and using them to bypass the blocked blood vessels.

“It’s the most common cardiac operation in the United States,” taking place 200,000 to 300,000 times a year, said Dr. Mario Gaudino, a cardiothoracic surgeon at Weill Cornell Medicine and lead author of the study.

Twenty-five to 30 percent of C.A.B.G. patients are women. How do they fare? The mortality rate for C.A.B.G., though low, is much higher for women (2.8 percent) than men (1.7 percent), Dr. Gaudino and his colleagues found.

Analyzing results from about 1.3 million patients (average age: 66) from 2011 to 2020, the researchers also determined that after C.A.B.G., about 20 percent of men had complications that included strokes, kidney failure, repeat surgeries, infections of the sternum and prolonged respirator use and hospital stays. Among women, more than 28 percent did.

A health worker fits a blood pressure sleeve onto Ms. Mosson's arm left arm in a hospital.
Cardiac and pulmonary rehabilitation respiratory therapist Abbey Smit, right, took Ms. Mosson’s blood pressure at a rehabilitation appointment at IU Health Frankfort Hospital.Kaiti Sullivan for The New York Times

Of those complications, “many are relatively minor and self-resolving,” Dr. Gaudino said. But recovering from sternal wound infections can take months, he noted, and “if you have a stroke, that can affect you for a long time.” Though outcomes improved for both sexes over the decade, the gender gap remained.

The study “should be regarded as an exploding flare in the sky for all clinicians who care for women,” an accompanying editorial said. Yet to cardiac researchers, the results sounded familiar.

“This has been something we’ve known since the 1980s,” said Dr. C. Noel Bairey Merz, a cardiologist and researcher at Cedars-Sinai Medical Center. Heart disease, she pointed out, remains the leading cause of death for American women.

With C.A.B.G., “the general assumption was that it was getting better because the technology, the knowledge, the skills and training were all improving,” she said. To see the gender disparity persist “is very disappointing.”

Several factors help explain those differences. Women are three to five years older than men when they undergo bypass surgery, in part because “we recognize coronary artery disease more easily and earlier in men,” Dr. Gaudino said. “Men have the classic presentation we study in medical school. Women have different symptoms.” These may include fatigue, shortness of breath and pain in the back or stomach.

Fewer than 20 percent of patients enrolled in clinical trials have been female, so “what we’ve been taught is essentially based on research in men,” he added.

Partly because they’re older — about 40 percent are over 70 — women are more apt than men to have developed health problems like diabetes, high blood pressure and vascular conditions, “all factors that increase risk in cardiac surgery,” Dr. Gaudino said. They also have smaller, more fragile blood vessels, which can make surgery more complex.

The disparities affect other forms of cardiac treatment and surgery, too. Women have worse outcomes than men five years after receiving a stent, a 2020 review of randomized trials reported.

Ms. Mosson’s daily medications.Kaiti Sullivan for The New York Times

They’re “less likely to be prescribed and to take statins, and particularly less likely to take the high-intensity statins, which are the most lifesaving,” Dr. Bairey Merz said. “The list goes on and on.”

When C.A.B.G. works well, the results can feel miraculous. Rhonda Skaggs, 68, had a quadruple bypass in July 2022 and spent 12 days in intensive care before going home to Brooksville, Fla. Six months passed before she returned to work at a Home Shopping Network outlet store.

“Now, you’d never know I had open-heart surgery,” she said. “I walk 10,000 steps a day. I teach line dance classes twice a week. I have my life back.”

But Susan Leary, 71, a retired New York City teacher now living in Fuquay-Varina, N.C., is facing a second procedure after bypass surgery at Duke University last month.

“Women are less likely to get all the vessels that need to be bypassed bypassed,” said her cardiothoracic surgeon, Dr. Brittany Zwischenberger, co-author of the call-to-arms editorial in JAMA Surgery.

A few years before, Ms. Leary had sought a procedure to shrink away the “ugly-looking” varicose veins in her legs; now, she lacked viable blood vessels for grafting. “How did I know I was going to need some of those veins for my heart?” she said.

She had a double bypass, instead of the triple bypass she needed, which represents “incomplete revascularization.”

“It can contribute to worse outcomes and future interventions,” Dr. Zwischenberger said. “Fortunately, she’s a candidate for a stent” for the third blocked artery, which involves inserting a mesh tube into the vessel to widen it. The procedure is scheduled for next month.

Advocates of improved care for women argue that their surgical risks can be reduced.

Dr. Lamia Harik, a cardiothoracic surgery researcher at Weill Cornell Medicine, and her colleagues have found that nearly 40 percent of women’s mortality during C.A.B.G. stems from interoperative anemia. (Their study is in press.)

On the treadmill during her rehabilitation appointment. Ms. Mosson has begun a three-times-weekly cardiac rehab program, recommended for patients who’ve undergone bypass surgery. She finds that her stamina is improving.Kaiti Sullivan for The New York Times

That occurs when operating teams administer fluids to dilute patients’ blood during the procedure, allowing them to use the large cardiopulmonary bypass machine (“the pump”) that keeps blood oxygenated and flowing while surgeons do the grafting.

“This is something modifiable,” Dr. Harik said. For women, surgeons might use smaller pumps or reduce the volume of added fluid, or both.

To learn more, Dr. Gaudino and other researchers have begun enrolling women, and only women, in two new clinical trials. The international ROMA study, the first all-female surgical trial, will investigate two C.A.B.G. techniques to see which produces better outcomes; the federally funded Recharge trial will compare stenting with C.A.B.G.

“In the past, a lot of surgeons thought this was inevitable,” Dr. Gaudino said of the differences between the sexes. “Maybe they will not disappear, but they can be minimized.”

Ms. Mosson said her surgeons were pleased with the results of her quadruple bypass, though she was readmitted to the hospital briefly for fluid in her lungs. She has begun a three-times-weekly cardiac rehab program, recommended for patients who’ve undergone bypass surgery, and finds that her stamina is improving.

She still contends with the psychological aftermath of her heart attack and surgery, as Ms. Skaggs did and Ms. Leary still does. They describe shock — none had a history of heart disease — depression and anxiety. “I’m still struggling with the fear it will happen again,” Ms. Mosson said.

One antidote, for Ms. Leary, was being recruited for ROMA; Duke is among the clinical trial sites. She jumped at the chance to enroll.

“Let me be a part of it,” she said. “Maybe my daughter will need this information someday.”

Adblock test (Why?)



Health - Latest - Google News
January 20, 2024 at 09:53PM
https://ift.tt/0ZflCAP

The Heart Surgery That Isn't as Safe for Older Women - The New York Times
Health - Latest - Google News
https://ift.tt/bjCm41s

Hallucinations, headaches, bizarre behavior shadow a teen’s pregnancy - The Washington Post

On the day after Christmas 2021, Abigail Aguilar, 18, and nearly three months pregnant, walked into her mother’s bedroom and in a flat, emotionless voice announced, “Mom, I’m going to slit my throat.”

For weeks Quintina Sims had grappled with her daughter’s increasingly bizarre and frightening behavior. Aguilar had also been plagued by unremitting nausea, splitting headaches and weakness so severe her stepfather sometimes had to carry her to the bathroom. Doctors had largely brushed off her symptoms as the normal manifestations of early pregnancy.

Aguilar’s threat triggered a cascade of events that would end in a hospital 130 miles south of her Kern County, Calif., home where doctors mobilized in an effort to discover what was making the previously healthy teenager so sick.

After treatment after treatment failed, Sims, now 42, would be called upon to make what she called “the hardest decision of my life” — one that appears to have saved her daughter.

Aguilar, who will turn 21 in a few weeks, is now working full time as a preschool teacher’s assistant and studying child development at a community college. She remembers very little of her harrowing six-week stay at Loma Linda University Medical Center, but says the months she spent recovering proved to be clarifying.

“It made me realize that I had to value my life a lot more,” Aguilar said. “And I learned that my family was always going to be there for me.”

An unexpected surprise

In the fall of 2021, Aguilar, a recent high school graduate, was living with her grandparents in Los Angeles, working in a movie theater and going to college part time.

In October, she discovered she was pregnant; the baby was due in July 2022. “It was a surprise,” she recalled. Aguilar, who was unmarried, struggled with what to do. She decided to have the baby, a decision her mother supported. “At first everything was fine,” Aguilar said.

But what began as normal morning sickness quickly morphed into near-constant vomiting accompanied by severe headaches. Aguilar’s older brother, who lived nearby, took her to an emergency room several times. She was diagnosed with migraines and hyperemesis gravidarum, a pregnancy-related condition that causes severe vomiting. Doctors gave her headache medicine and fluids. Aguilar lost about 10 pounds in a matter of weeks and suffered from headaches so piercing she sometimes wore sunglasses indoors.

Doctors, however, “didn’t see anything of concern,” said her mother, a graphic designer. “I was very concerned. Abby was constantly calling me and she looked different.” At times “she seemed really out of it.”

By mid-November Aguilar felt so ill that she moved back to her parents’ home and began seeing a new obstetrician. Her mother, who accompanied her to appointments, said the new doctor also attributed Aguilar’s worsening condition to her pregnancy and did not seem worried.

On Dec. 14, after Aguilar complained of a stiff neck, her mother called her health insurer’s emergency line. A doctor advised her to take her daughter to an ER immediately, in case she had meningitis, swelling that affects the brain and spinal cord and requires immediate treatment.

At one point “she was looking at me with a blank look and said, ‘I died, I know I died,’”
— Quintina Sims

“We waited 4 or 5 hours, and they did an ultrasound and blood tests and said ‘Yeah, it just has to be part of the pregnancy,’” Sims recalled. Doctors prescribed muscle relaxants and steroids and sent the pair home.

Nearly 10 weeks pregnant, Aguilar had suddenly developed severe insomnia; she slept in 30-minute snatches, a total of about three hours per night. Her personality had changed dramatically. Sometimes she was “very bland,” Sims said, while the next day she seemed deeply depressed and couldn’t stop crying.

“We kept a really close eye on her,” said Sims, who took her daughter back to the ER for the insomnia and depression, their second trip that week. Doctors tested Aguilar for a urinary tract infection and, finding none, predicted her condition would improve as the pregnancy progressed.

But on Christmas Day, Aguilar seemed worse. She stared at her gifts, apparently unable to comprehend what they were. At one point “she was looking at me with a blank look and said, ‘I died, I know I died,’” Sims recalled. Her family again carted her off to the ER, where a doctor gave her a sedative. He told Sims that her daughter might be displaying signs of “pregnancy psychosis,” which would be extremely unusual in someone like Aguilar who had no prior mental health diagnosis.

‘Not a mental health issue’

The following day, after Aguilar announced her intention to cut her throat, Sims called police for help. When Aguilar told an officer she planned to use a kitchen knife, police transported her to a mental health clinic. “She seemed normal when we got there and refused to sign herself in,” Sims said.

But in a moment that proved to be both pivotal and prophetic, a nurse pulled Sims and her husband aside. “She said, ‘This is not a mental health issue,” Sims recalled. “You need to take her to Loma Linda right now.’”

Sims didn’t ask questions. “For us, hearing that was a validation,” she said. The couple bundled their four children into the car and began making the two-hour drive south to Loma Linda, one of the teaching hospitals nearest their home.

Worried that Aguilar might try to jump out of the moving car, her older brother sat beside her in the back seat as the family sang and played Disney songs, hoping to distract her. They arrived at the hospital shortly after midnight.

In the ER, Aguilar quickly became agitated and psychotic. She pulled a woman’s hair, tried to take her clothes off and run out the door, and kicked a nurse taking her vital signs. She was admitted and placed on a 72-hour involuntary psychiatric hold as doctors sought to determine what was wrong.

One possibility, a psychiatrist told Sims, was schizophrenia, a serious mental illness characterized by delusions and hallucinations. Aguilar was hallucinating and alternating between periods of gibberish — repeating the names and addresses of family members over and over — and catatonia, which is characterized by unusual physical movements and long periods of not speaking.

“It was the hardest decision of my life. I spoke with my husband, her siblings, my dad, my mom, and I had a conversation with God about it.”
— Quintina Sims

Doctors soon suspected that a mental illness was not the underlying cause. Aguilar’s headaches, stiff neck and catatonia were suggestive of a neurological problem, said Travis Losey, chair of neurology and one of the doctors involved in her care. A physical exam found that her reflexes were abnormal, as was an electroencephalogram (EEG), which measures electrical activity in the brain. The focus shifted to an infection, a brain tumor or epilepsy.

An MRI revealed no sign of a tumor or other abnormality, and testing found no sign of epilepsy. Aguilar’s abnormal spinal tap pointed to the possibility of a rare, life-threatening disease called anti-NMDA receptor encephalitis. The illness, discovered in 2007, disrupts signaling in the brain and can be triggered by an infection or an autoimmune reaction in which the body attacks itself. It often strikes teenage girls and young women and is estimated to affect 1 in 1.5 million people per year.

Confusion, personality changes and hallucinations are common in the first weeks of the illness, which can be mistaken for schizophrenia. In later stages, seizures, sometimes prolonged, can occur. Without treatment, coma, permanent brain damage or death may result.

Doctors sent samples of Aguilar’s blood and spinal fluid to the Mayo Clinic. Two weeks later they learned that telltale antibodies had been found in her spinal fluid, confirming the encephalitis diagnosis.

But Aguilar’s pregnancy raised fraught and difficult questions about her treatment for which there was virtually no guidance. Fewer than 35 cases of the new disease had been reported in pregnant women worldwide, and safety questions about the potentially toxic effects on a fetus of the drugs used to treat it remain unresolved. Doctors from several departments including obstetrics and gynecology and medical ethics had joined the team caring for her.

After the first-line treatment — intravenous steroids — failed doctors began infusions of rituximab, a monoclonal antibody sometimes used to treat certain cancers and serious autoimmune diseases, a drug Losey called “the big gun.” Because of its possible hazards to a developing fetus, patients are warned not to take it if they are or may become pregnant.

Meanwhile doctors also began searching for a usually benign ovarian tumor called a teratoma that can cause encephalitis.

A fateful decision

In late January, a doctor removed a teratoma and a walnut-sized cyst on Aguilar’s left ovary.

But to the dismay of her medical team, neither the rituximab infusions nor the tumor removal made any difference. Aguilar was getting worse, not better. She did not know why she was in the hospital, did not remember she was pregnant and described seeing ghosts in her hospital room.

Her doctors, who had consulted the hospital’s lawyers, broached a difficult subject with Sims. They had run out of treatment options and advised Sims that ending the pregnancy might be the best chance to save her daughter’s life. It seemed unlikely that both she and her baby would survive.

In some cases they told her, pregnancy might exacerbate anti-NMDA receptor encephalitis, possibly as a result of hormonal changes. The longer Aguilar remained ill, the greater the risk to her life. And because doctors had found her to be incapable of making a decision about a therapeutic abortion, it would fall to her mother to make it for her.

“The goal is, ‘What would the patient decide if the patient were able to make the decision?’” Losey said. “In this case, the family had a very clear understanding of what their role was.”

Sims said that doctors reviewed with her the results of the few published studies. A 2020 report of 11 pregnancies found that most babies born to mothers with anti-NMDA receptor encephalitis appeared to be healthy at birth, although 55 percent were premature. There were no deaths. The authors also analyzed 21 other cases reported between 2010 and 2019; two mothers died of septic shock, two had miscarriages and two had abortions. Of 16 births, nine were premature and one baby died shortly after birth.

“I knew this decision was going to have to be mine,” Sims said. “I had to choose between [Abby] and the baby, who might not have a mother.”

“It was the hardest decision of my life,” added Sims, who had suffered a miscarriage in her 20s. “I spoke with my husband, her siblings, my dad, my mom, and I had a conversation with God about it. Everyone told me the same answer: It’s okay to choose Abby.”

Aguilar, then about 17 weeks pregnant, underwent a surgical abortion Feb. 7. Her family and her doctors waited anxiously to see what would happen.

Stunning turnaround

The morning after the procedure Sims walked into her daughter’s hospital room and was stunned by what she saw. “Abby was walking out of the bathroom by herself, and she was able to write her name legibly,” Sims recalled, actions that would have been impossible a day or two earlier. “I just started crying.”

Aguilar was discharged Feb. 12. Her recovery took several months as her symptoms receded and she was weaned off a variety of medications. The enormity of what she had been through, coupled with temporary physical changes caused by the steroids and other drugs and the loss of her pregnancy, were wrenching.

“All my friends were having babies,” she said. “I think I felt a lot of self-hate and self-pity, like why did this happen to me? But at the end of the day, you don’t choose what happens to you.” She decided to return to school, get a job and focus on her future.

In December 2022, there was an unexpected development: Aguilar was pregnant again, much to her surprise. She opted to continue the pregnancy.

“I wasn’t angry or sad,” her mother said. “I was scared.”

Because there was a chance she could relapse, Aguilar was closely monitored by a neurologist and two obstetricians, one a high-risk specialist. “This pregnancy was so smooth,” observed Sims, who said her daughter experienced no complications. “I was nervous the whole time. I was constantly texting her and at doctors’ appointments with her.”

Sims was in the delivery room when her first grandchild, a girl, was born “perfectly healthy” in August 2023. The baby, Sims said, “is a little reminder that I did what I needed to do.”

Aguilar agrees. “Now that I have my own daughter,” she said, “I would do the exact same thing.”

Submit your solved medical mystery to sandra.boodman@washpost.com. No unsolved cases, please. Read previous mysteries at wapo.st/medicalmysteries.

Adblock test (Why?)



Health - Latest - Google News
January 20, 2024 at 09:15PM
https://ift.tt/W8zKwpr

Hallucinations, headaches, bizarre behavior shadow a teen’s pregnancy - The Washington Post
Health - Latest - Google News
https://ift.tt/bjCm41s

Featured Post

Measles is “growing global threat,” CDC tells doctors in alert message - Ars Technica

Enlarge / A baby with measles. CDC The Centers for Disease Control and Prevention is putting clinicians on alert about the growing r...

Popular Posts